Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Linrodostat |
| Trade Name | |
| Synonyms | BMS986205|BMS 986205|ONO-7701|BMS-986205 |
| Drug Descriptions |
Linrodostat (BMS-986205) inhibits indoleamine 2,3-dioxygenase 1 (IDO1), which results in decreased breakdown of tryptophan into kynurenine in the tumor microenvironment, potentially resulting in enhanced anti-tumor immune response (PMID: 31823654, PMID: 33298590). |
| DrugClasses | IDO1 Inhibitor 13 |
| CAS Registry Number | 1923833-60-6 |
| NCIT ID | C141135 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BCG solution + Linrodostat + Nivolumab | BCG solution Linrodostat Nivolumab | 0 | 1 |
| Cisplatin + Gemcitabine + Linrodostat + Nivolumab | Cisplatin Gemcitabine Linrodostat Nivolumab | 0 | 1 |
| Ipilimumab + Linrodostat + Nivolumab | Ipilimumab Linrodostat Nivolumab | 0 | 1 |
| Linrodostat | Linrodostat | 0 | 0 |
| Linrodostat + Nivolumab | Linrodostat Nivolumab | 0 | 12 |
| Linrodostat + Nivolumab + Relatlimab | Linrodostat Nivolumab Relatlimab | 0 | 1 |
| Linrodostat + Nivolumab + Temozolomide | Linrodostat Nivolumab Temozolomide | 0 | 1 |